IPSEN BIOINNOVATION LTD has a total of 156 patent applications. It increased the IP activity by 325.0%. Its first patent ever was published in 2004. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are SYNTAXIN LTD, XL PROTEIN GMBH and ATYR PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 28 | |
#2 | United States | 27 | |
#3 | Australia | 22 | |
#4 | Japan | 11 | |
#5 | Taiwan | 10 | |
#6 | Hong Kong | 9 | |
#7 | Mexico | 8 | |
#8 | Hungary | 7 | |
#9 | Republic of Korea | 6 | |
#10 | China | 4 | |
#11 | Israel | 4 | |
#12 | Singapore | 4 | |
#13 | Ukraine | 4 | |
#14 | Canada | 3 | |
#15 | United Kingdom | 2 | |
#16 | Russian Federation | 2 | |
#17 | WIPO (World Intellectual Property Organization) | 2 | |
#18 | Brazil | 1 | |
#19 | New Zealand | 1 | |
#20 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Environmental technology | |
#5 | Measurement | |
#6 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Enzymes | |
#6 | Climate change adaptation technologies | |
#7 | Fermentation | |
#8 | Analysing materials | |
#9 | Measuring microorganism processes | |
#10 | Specific use of cosmetics |
# | Name | Total Patents |
---|---|---|
#1 | Foster Keith | 41 |
#2 | Liu Sai Man | 35 |
#3 | Marks Philip | 34 |
#4 | Hackett Gavin Stephen | 31 |
#5 | Rummel Andreas | 25 |
#6 | Anderson Dina Brady | 18 |
#7 | Chaddock John | 17 |
#8 | Cossins Aimee | 16 |
#9 | Beard Matthew | 15 |
#10 | Madec Frederic | 12 |
Publication | Filing date | Title |
---|---|---|
GB202011055D0 | Treatment of post-operative pain | |
JP2019206582A | Cationic neurotoxins | |
JP2019141096A | Methods for manufacture of proteolytically processed polypeptides | |
RU2719164C1 | Methods for producing proteolytically processed polypeptides | |
AU2018321405A1 | Evolution of BoNT peptidases | |
US2017327810A1 | Fusion proteins and methods for treating, preventing or ameliorating pain | |
JP2017127313A | Methods for manufacture of proteolytically processed polypeptides | |
GB201522291D0 | Delivery vehicle | |
AU2015268754A1 | Suppression of cancer | |
US2018141982A1 | Cationic neurotoxins | |
EP2677029A2 | Methods for the manufacture of proteolytically processed polypeptides | |
AU2009259033A1 | Suppression of neuroendocrine diseases | |
AU2005227383A1 | Inhibition of secretion from non-neuronal cells |